Order Article Reprints

Savoldi A, Morra M, Castelli A, Mirandola M, Berkell M, Smet M, Konnova A, Rossi E, Cataudella S, De Nardo P, et al. Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study. Biomedicines. 2022; 10(9):2063. https://doi.org/10.3390/biomedicines10092063

Savoldi, Alessia, Matteo Morra, Alessandro Castelli, Massimo Mirandola, Matilda Berkell, Mathias Smet, Angelina Konnova, Elisa Rossi, Salvatore Cataudella, Pasquale De Nardo, and et al. 2022. "Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study" Biomedicines 10, no. 9: 2063. https://doi.org/10.3390/biomedicines10092063

Savoldi, A., Morra, M., Castelli, A., Mirandola, M., Berkell, M., Smet, M., Konnova, A., Rossi, E., Cataudella, S., De Nardo, P., Gentilotti, E., Gupta, A., Fasan, D., Gibbin, E., Puviani, F. C., Hasenauer, J., Gusinow, R., Tami, A., Kumar-Singh, S., ... Tacconelli, E. (2022). Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study. Biomedicines, 10(9), 2063. https://doi.org/10.3390/biomedicines10092063